NCT07094451 Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures
| NCT ID | NCT07094451 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Procedural Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2027-04-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-07-02 with a primary completion date of 2027-04-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-site randomized controlled pilot study at Mount Sinai Hospital evaluating the effect of virtual reality on procedural pain and anxiety in obstetric patients undergoing ultrasound-guided needle procedures. Patients will be randomized to receive either VR or standard care during the procedure and complete validated questionnaires assessing pain, anxiety, intervention acceptability, and satisfaction.
Eligibility Criteria
Inclusion criteria: * Age ≥18 * English-speaking * Undergoing ultrasound-guided needle procedure at Mount Sinai Exclusion criteria: * History of seizures * Severe motion sickness
Contact & Investigator
Daniel Katz, MD
PRINCIPAL INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT07094451 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Procedural Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07094451 currently recruiting?
Yes, NCT07094451 is actively recruiting participants. Contact the research team at lucy.shang@icahn.mssm.edu for enrollment information.
Where is the NCT07094451 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07094451 clinical trial?
NCT07094451 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Daniel Katz, MD at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 50 participants.